Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1033 of 5804
-
Could Low-Dose radiation slow Alzheimer's? new trial aims to find out
Disease control Not yet recruitingThe goal of this randomized clinical trial is to investigate whether low-dose whole-brain radiotherapy has a potential immunomodulatory effect that may influence disease progression in patients with early-stage Alzheimer's disease (ICD-10 diagnosed). The main question(s) it aims…
Phase: NA • Sponsor: Heinrich-Heine University, Duesseldorf • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New drug combo aims to tackle obesity in major trial
Disease control Recruiting nowThe main purpose of this study, performed under the master protocol W8M-MC-CWMM (NCT06143956), is to examine the body weight-lowering efficacy and safety of macupatide plus eloralintide compared with placebo in participants with obesity or overweight and without type 2 diabetes. …
Phase: PHASE2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New combo drug trial hopes to shrink Hard-to-Treat cancers
Disease control Not yet recruitingThis study is a multi-center, open-label, dose-escalation and dose-optimized phase I/II clinical trial. Objective: To determine the safety, tolerability, PK characteristics and preliminary efficacy data of CVL006 combined with 9MW821 patients with advanced solid tumors.
Phase: PHASE1, PHASE2 • Sponsor: Convalife (Shanghai) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
One pill to prevent HIV and pregnancy? new study tests simpler option for women
Prevention Not yet recruitingTo evaluate adherence to a single dual-prevention pill (DPP) compared with a two-pill regimen (2PR) for pre-exposure prophylaxis (PrEP) and pregnancy prevention in women without HIV.
Phase: PHASE2 • Sponsor: HIV Prevention Trials Network • Aim: Prevention
Last updated Jun 27, 2026 09:06 UTC
-
Gene therapy injection aims to control rare brain disease in children
Disease control Not yet recruitingA phase I/II clinical study to evaluate the tolerance, safety and efficacy of VGN-R08b intracerebroventricular injection in patients with type III Gaucher's disease
Phase: PHASE1, PHASE2 • Sponsor: Shanghai Vitalgen BioPharma Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Shockwaves or magnets? new trial tests two therapies for Women's sexual health
Symptom relief Recruiting nowThis is a prospective, three-arm, parallel-group, assessor-blinded randomized controlled trial designed to compare the effectiveness of extracorporeal shockwave therapy (ESWT) combined with pelvic floor muscle training (PFMT), pulsed electromagnetic field stimulation (PEMF) combi…
Phase: NA • Sponsor: Benha University • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
New antibiotic OMN6 tested against tough lung infection
Disease control Recruiting nowThis is a phase 2a, multinational, multicenter, double-blind, randomized, placebo-controlled, dose-ranging safety, tolerability and PK study in patients with HABP (Hospital Acquired Bacterial Pneumonia) or VABP (Ventilator Associated Bacterial Pneumonia) caused by ABC to identify…
Phase: PHASE2 • Sponsor: Omnix Medical Ltd • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New study tackles double malnutrition burden in guatemala
Disease control Recruiting nowGlobally, populations are experiencing increases in the double burden of malnutrition, commonly defined as maternal overweight/obesity and child stunting in the same household. This study will evaluate an integrated intervention combining food supplementation for pregnant and pos…
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Could a quick ketamine infusion lift depression in ICU patients?
Symptom relief Recruiting now\*\*Brief Summary\*\* Depressive symptoms are frequent among patients admitted to the intensive care unit (ICU) and may be associated with worse clinical outcomes, reduced participation in care, lower treatment adherence, and increased mortality. Conventional antidepressants, in…
Phase: PHASE2 • Sponsor: Hospital Italiano de Buenos Aires • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
Personalized combo therapy aims to overcome drug resistance in kidney cancer
Disease control Not yet recruitingGiven the significant challenge of drug resistance in patients with advanced renal cell carcinoma (RCC) despite standard treatment, this study aims to translate preclinical findings into clinical practice, preliminarily evaluating the safety, tolerability, and preliminary efficac…
Phase: PHASE1, PHASE2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Can acceptance and commitment therapy ease chronic pain as well as CBT?
Symptom relief OngoingThis study is evaluating whether Acceptance and Commitment Therapy (ACT) helps adults with chronic non-malignant pain (pain lasting 3 months or longer that is not caused by cancer). Sixty adult participants (ages 18-60) were randomly placed into one of three groups: ACT, Cognitiv…
Phase: NA • Sponsor: GIFT University • Aim: Symptom relief
Last updated Jul 18, 2026 00:00 UTC
-
New hope for recurrent ovarian cancer? early trial combines novel PARP inhibitor with chemo
Disease control Recruiting nowThis is a multicenter, open-label Phase Ia/b study on the safety and efficacy of the combination of NMS-03305293 and topotecan in patients with recurrent ovarian cancer, with dose-limiting toxicity (DLT) escalation. The aim of this study is to determine the safety and tolerabilit…
Phase: PHASE1 • Sponsor: Nerviano Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
Could a 4-Week radiation course be as good as 5 weeks for prostate cancer?
Disease control Recruiting nowStudy Overview This research compares two types of post-operative salvage radiotherapy (SRT) for men with prostate cancer who have had surgery but show signs of recurrence (detectable PSA). The goal is to see if a shorter treatment schedule is as safe and effective as the standar…
Phase: NA • Sponsor: CHU de Quebec-Universite Laval • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New drug trial aims to tame muscle weakness in myasthenia gravis
Disease control Recruiting nowThe purpose of this study is to evaluate the pharmacodynamic (PD) effect, safety, and tolerability of Povetacicept in participants with generalized myasthenia gravis (gMG).
Phase: PHASE2 • Sponsor: Vertex Pharmaceuticals Incorporated • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New insulin pump aims to tame blood sugar swings
Disease control Recruiting nowThis multi-center, randomized, cross-over trial will evaluate the efficacy of the Omnipod 6 System compared with the Omnipod 5 System in individuals with type 1 or type 2 diabetes and suboptimal glycemia.
Phase: NA • Sponsor: Insulet Corporation • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New hope for elderly lung cancer: One-Drug immunotherapy trial launches
Disease control Recruiting nowThis prospective clinical study aims to evaluate and observe the efficacy and safety of Serplulimab Monotherapy in Elderly Patients with NSCLC and PD-L1 TPS ≥ 50% using a multicenter, single-arm, phase II design. The study is planned to be conducted in Shaanxi Province, China, w…
Phase: PHASE2 • Sponsor: Tang-Du Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Saline wash may offer safer way to treat lung infections
Disease control Recruiting nowIntrapleural enzyme therapy (IET) is regarded by recent guidelines as a "rescue" therapy for managing complicated pleural infections; however, it is associated with significant side effects, including pleural bleeding, pain, and fever. Pleural irrigation with saline may serve as …
Phase: PHASE3 • Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Could a nerve drug boost GIST treatment? early trial begins.
Disease control Recruiting nowThe goal of this clinical trial is to learn what dose of the drug fampridine can be given safely together with imatinib (Gleevec) in patients with gastrointestinal stromal tumor (GIST) with a DNA mutation in exon 11 of the KIT gene. The main questions this study aims to answer a…
Phase: PHASE1 • Sponsor: University of California, San Diego • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Can a sleep machine stop heart rhythm problems after ablation?
Disease control Recruiting nowAtrial fibrillation (AF) is one of the most common clinical arrhythmias. Catheter ablation is an effective therapeutic strategy; however, recurrence rates remain substantial, ranging from 20% to 45%. Previous studies have established a strong association between obstructive sleep…
Phase: NA • Sponsor: Beijing Anzhen Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug combo aims to tame painful muscle condition and cut steroid dependence
Disease control Recruiting nowThis is a randomized, double-blind, placebo-controlled, parallel-group, Phase 4, 3-group study to assess whether treatment with sarilumab at either 150 mg q2w (once every two weeks) or at 200 mg q2w, each given with a 52-week prednisone taper, is superior to placebo given with a …
Phase: PHASE4 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC